Rachel Yehuda

Marty McCary is a renowned surgeon and public policy researcher, while Cara Anthony investigates trauma and violence as a reporter, and Rachel Yehuda is a distinguished professor studying intergenerational trauma. They discuss how outdated medical guidelines on peanut allergies led to unintended consequences and highlight the shocking legacy of trauma within communities, particularly among descendants of Holocaust survivors. The conversation dives into the importance of understanding these ripple effects for better health outcomes and emotional healing.

Dr. Rachel Yehuda, expert in trauma and psychedelics, discusses Jewish trauma, ancestral healing, and the future of MDMA therapy. They explore the influence of family, PTSD treatment, intergenerational trauma in Jewish communities, and the transformative power of psychedelics. The conversation connects Passover traditions to healing, resilience, and freedom.

Dr. Charles Raison and Dr. Rachel Yehuda discuss the potential of psilocybin for treating major depressive disorder. They cover the study design, findings, limitations, side effects, and the importance of blinding in psilocybin research. They also explore the sustained gains in mental health seen after psilocybin treatment. The podcast highlights the unique effects of psilocybin and the need for future research on psychedelic therapies for mental health care.

In this discussion, Rachel Yehuda, a leading expert in PTSD and epigenetics, delves into how trauma can transcend generations. She explains the complex role cortisol plays as both a stress and anti-stress hormone, reshaping our understanding of the stress response. Rachel highlights the impact of intergenerational trauma on mental health and discusses the importance of gratitude and forgiveness in healing. She also touches on the promise of psychedelics in treating PTSD, urging further exploration of their therapeutic potential.

In this enlightening discussion, psychiatrist James Murrow explores ketamine's groundbreaking effects on depression, while Rachel Yehuda reveals the potential of MDMA-assisted therapy for PTSD. Yasmin Hurd dives into the role of CBD in combating opioid addiction. Together, they unveil how recreational drugs are transforming psychiatry, addressing both their promise and regulatory challenges. The conversation highlights the shift in perception regarding these substances and their increasing relevance in mental health treatment.